CN101874851B - Traditional Chinese medicine for treating chronic infectious arthritis - Google Patents

Traditional Chinese medicine for treating chronic infectious arthritis Download PDF

Info

Publication number
CN101874851B
CN101874851B CN2009100832223A CN200910083222A CN101874851B CN 101874851 B CN101874851 B CN 101874851B CN 2009100832223 A CN2009100832223 A CN 2009100832223A CN 200910083222 A CN200910083222 A CN 200910083222A CN 101874851 B CN101874851 B CN 101874851B
Authority
CN
China
Prior art keywords
chinese medicine
parts
traditional chinese
radix
fine powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009100832223A
Other languages
Chinese (zh)
Other versions
CN101874851A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Danfang Textile Research and Development Co Ltd
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2009100832223A priority Critical patent/CN101874851B/en
Publication of CN101874851A publication Critical patent/CN101874851A/en
Application granted granted Critical
Publication of CN101874851B publication Critical patent/CN101874851B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine for treating chronic infectious arthritis, and belongs to the field of traditional Chinese medicines for treating rheumatism. The traditional Chinese medicine aims to have good effect and quick response. The traditional Chinese medicine is prepared from raw materials such as gentiana macrophylla, Chinese angelica, radix stephaniae tetrandrae, kadsura pepper stem, rehmanniae praeparatum, glossy ganoderma, earthworm, notoginseng root, ovientvine and the like. The traditional Chinese medicine has the effects of strengthening body resistance and archaeus, supplementing qi and nourishing blood, promoting blood circulation by removing blood stasis, promoting channels and collaterals and dispelling the wind and arthritis, and has the advantages of obvious effect, definite medicinal effect and quick response.

Description

一种治疗类风湿性关节炎的中药A kind of traditional Chinese medicine for treating rheumatoid arthritis

技术领域technical field

本发明属于治疗风湿病的中药领域。The invention belongs to the field of traditional Chinese medicine for treating rheumatism.

背景技术Background technique

目前用于治疗类风湿性关节炎的中药,存在几个方面的不足:一是效果不够明显,二是见效比较迟缓,以致于大批类风湿性关节炎患者晨僵和关节疼痛、关节肿胀、关节畸形长期得不到有效缓解,非常痛苦,患者及其家属对此不满意。The traditional Chinese medicine that is currently used for the treatment of rheumatoid arthritis has several deficiencies: one is that the effect is not obvious enough; The deformity has not been effectively alleviated for a long time, which is very painful, and the patients and their families are not satisfied with it.

针对以上提出的问题,本发明提供一种治疗类风湿性关节炎的中药,它能解决以往此类中药治疗中效果不够明显,见效比较迟缓的问题,效果好、见效快,具有效果显著,药效确切,见效较快的优点。In view of the problems raised above, the present invention provides a traditional Chinese medicine for treating rheumatoid arthritis, which can solve the problem that the effect of this type of traditional Chinese medicine is not obvious enough in the past, and the effect is relatively slow. The advantages of definite effect and quicker effect.

发明内容Contents of the invention

本发明是通过以下技术方案来实现的:The present invention is achieved through the following technical solutions:

1、一种治疗类风湿性关节炎的中药,采用中药原料制备,配方为(按重量比):1, a kind of Chinese medicine for the treatment of rheumatoid arthritis, adopts Chinese medicine raw material to prepare, and formula is (by weight):

秦艽4——25份      当归5——30份    防己4——25份Gentiana 4——25 parts Angelica 5——30 parts Fangji 4——25 parts

海风藤4——25份    生地5——30份    灵芝4——20份Sea Wind Vine 4——25 parts Shengdi 5——30 parts Ganoderma lucidum 4——20 parts

地龙3——18份      三七3——18份    青风藤4——25份Earth Dragon 3——18 copies Sanqi 3——18 copies Qingfengteng 4——25 copies

这种治疗类风湿性关节炎的中药是由下列方法制成的:This traditional Chinese medicine for treating rheumatoid arthritis is made by the following methods:

(1)按上述重量比,将秦艽、当归、防己、海风藤、生地、青风藤经常规水提取工艺提取,制成浸膏细粉;(1) According to the above-mentioned weight ratio, Gentiana chinensis, Angelica sinensis, Fangji, Caulis Caulis, Rehmannia, and Caulis chinensis are extracted through a conventional water extraction process to make extract powder;

(2)按上述重量比,将灵芝、地龙、三七分别研成细粉,与上述浸膏细粉混合,搅拌均匀;根据需要,可制成中药冲剂、颗粒剂、散剂、胶囊剂、水丸剂、片剂等剂型。(2) Grind ganoderma lucidum, earthworm, and notoginseng into fine powders according to the above weight ratio, mix with the above-mentioned extract powder, and stir evenly; Dosage forms such as water pills and tablets.

本发明是根据民间传统配方,根据中医扶正培本、活血化瘀的理论,精心研制而成。方中秦艽一药多能,治疗痹证、风寒湿热皆可应用,并且病发无问新久,病情无问轻重,均可用之;防己善除风寒湿邪,长于消肿,二药相伍除风湿病痛效果更好;灵芝、生地扶正培本、益气养血;三七、地龙、当归活血化瘀;伍以青风藤、海风藤取藤之通络之功,通利经络,为治疗关节不利、麻木、拘挛之不可或缺。诸药配伍,相得益彰,共奏扶正培本,益气养血,活血化瘀,通利经络、祛风寒痹病之功,效果好,见效快,具有效果显著,药效确切,见效较快的优点。The present invention is elaborately developed according to the folk traditional formula and the theory of traditional Chinese medicine of strengthening the body and strengthening the body, promoting blood circulation and removing blood stasis. In the prescription, Gentiana chinensis has multiple functions, and it can be used to treat arthralgia syndrome, wind-cold, damp-heat, and it can be used regardless of the duration of the onset of the disease and the severity of the condition; Fangji is good at eliminating wind-cold-damp pathogens, good at reducing swelling, and the two medicines are combined The effect of removing rheumatism is better; Ganoderma lucidum, Shengdi Fuzheng Peiben, nourishing qi and blood; Panax notoginseng, earthworm, and angelica promote blood circulation and remove blood stasis; fifth, Qingfengteng and Haifengteng take the merit of dredging collaterals, which can benefit the meridians, Indispensable for the treatment of unfavorable joints, numbness, and spasms. All the medicines are compatible and complement each other. They play the role of strengthening the body, nourishing qi and blood, promoting blood circulation and removing blood stasis, dredging the meridians, and dispelling wind-cold arthralgia. It has good effect and quick effect. advantage.

具体实施方式Detailed ways

通过以下实施方式对本发明做具体说明:The present invention is specifically described by the following embodiments:

1、取以下配方(重量按克为单位):1. Take the following formula (weight is in grams):

秦艽50克      当归50克    防己50克Gentiana 50g Angelica 50g Fangji 50g

海风藤50克    生地60克    灵芝50克Sea Breeze Vine 50g Rehmannia 60g Ganoderma lucidum 50g

地龙30克      三七30克    青风藤50克Dilong 30g Sanqi 30g Qingfengteng 50g

按规定重量,用常规水提取工艺将秦艽、当归、防己、海风藤、生地、青风藤提取,制成浸膏细粉77.5克,将灵芝、地龙、三七分别研成细粉,与上述浸膏细粉混合,搅拌均匀,制成细小颗粒,装入0号胶囊,制成中药胶囊670粒,每粒胶囊内含中药细粉及提取物0.28克。According to the specified weight, use the conventional water extraction process to extract Gentiana, Angelica, Fangji, Haifengteng, Shengdi, and Qingfengteng to make 77.5 grams of extract powder, and grind Ganoderma lucidum, Dilong, and Sanqi into fine powders, and The above-mentioned extract powders are mixed, stirred evenly, made into fine particles, packed into No. 0 capsules, and made into 670 Chinese medicine capsules, each capsule containing 0.28 grams of Chinese medicine fine powder and extract.

2、取以下配方(重量按克为单位):2. Take the following formula (weight is in grams):

秦艽120克      当归150克    防己120克Gentiana 120g Angelica 150g Fangji 120g

海风藤160克    生地160克    灵芝110克Sea Breeze Vine 160g Rehmannia 160g Ganoderma lucidum 110g

地龙110克      三七120克    青风藤120克Dilong 110g Sanqi 120g Qingfengteng 120g

按上述同样的方法,制成中药胶囊1955粒,每粒胶囊内含中药细粉及提取物0.28克。By above-mentioned same method, make 1955 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.

3、取以下配方(重量按克为单位):3. Take the following formula (the weight is in grams):

秦艽250克      当归300克    防己250克Gentiana 250g Angelica 300g Fangji 250g

海风藤250克    生地250克    灵芝200克Sea Breeze Vine 250g Rehmannia 250g Ganoderma lucidum 200g

地龙180克      三七180克    青风藤220克Dilong 180g Sanqi 180g Qingfengteng 220g

按上述同样的方法,制成中药胶囊3357粒,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, 3357 Chinese medicine capsules were made, and each capsule contained Chinese medicine fine powder and 0.28 grams of extract.

4、取以下配方(按重量比):4. Take the following formula (by weight):

秦艽6份      当归8份    防己6份6 parts of Gentiana 8 parts of Angelica 6 parts of Fangji

海风藤6份    生地8份    灵芝6份6 parts of sea wind vine, 8 parts of raw land, 6 parts of Ganoderma lucidum

地龙4份      三七4份    青风藤6份4 parts of Dilong 4 parts of Panax notoginseng 6 parts of Qingfengteng

按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.

5、取以下配方(按重量比):5. Take the following formula (by weight):

秦艽22份      当归30份    防己22份Gentiana 22 parts Angelica 30 parts Fangji 22 parts

海风藤22份    生地30份    灵芝18份22 parts of sea wind vine, 30 parts of raw land, 18 parts of Ganoderma lucidum

地龙15份      三七15份    青风藤22份15 parts of Dilong 15 parts of Panax notoginseng 22 parts of Qingfengteng

按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.

临床资料:clinical information:

本发明以中医类风湿性关节炎为例,经17例临床观察。选择中医诊断类风湿性关节炎为标准:体质虚弱,肢软乏力;关节晨僵,超1小时;关节疼痛,关节肿胀,内有积液;关节畸形,呈梭形肿大。如上症状,即可确诊。在确诊观察的对象中,男性11例,女性6例,无其它严重疾病,年龄为37岁-62岁,平均年龄47.7岁。The present invention takes TCM rheumatoid arthritis as an example, through clinical observation of 17 cases. TCM diagnosis of rheumatoid arthritis was selected as the standard: physical weakness, limb weakness; joint morning stiffness, more than 1 hour; joint pain, joint swelling, with effusion; joint deformity, fusiform swelling. The above symptoms can be diagnosed. Among the confirmed observation objects, there were 11 males and 6 females, without other serious diseases, aged from 37 to 62 years old, with an average age of 47.7 years.

疗效判定:Judgment of curative effect:

1、显效:身上有劲;晨僵和关节疼痛、关节肿胀、关节畸形明显缓解。1. Significant effect: strong body; morning stiffness, joint pain, joint swelling, and joint deformity are significantly relieved.

2、有效:身上有劲,晨僵和关节疼痛、肿胀、畸形有所缓解。2. Effective: the body has strength, morning stiffness, joint pain, swelling, and deformity are relieved.

3、无效:病症无变化。3. Ineffective: no change in symptoms.

临床实验时,停服其它药物和保健营养品。服用本发明中药胶囊,观察3个月,为一个疗程。服用方法:每日3次,每次5胶囊,每粒胶囊内含中药细粉及提取物0.28克,饭后温开水送服,1个月后症状即有缓解,服用6个月后,症状明显改善。临床实验的17人中,显效9人,有效6人,无效2人,总有效率88.2%。During the clinical trial, stop taking other medicines and health nutrition products. Take Chinese medicine capsule of the present invention, observe 3 months, be a course of treatment. Dosing method: 3 times a day, 5 capsules each time, each capsule contains 0.28 grams of fine powder and extract of traditional Chinese medicine, take it with warm water after meals, the symptoms will be relieved after 1 month, and the symptoms will disappear after 6 months of taking Significant improvement. Among the 17 people in the clinical trial, 9 were markedly effective, 6 were effective, and 2 were ineffective, with a total effective rate of 88.2%.

Claims (1)

1. a Chinese medicine for the treatment of rheumatoid arthritis is characterized in that, described Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Radix Gentianae Macrophyllae 4---25 parts of 25 parts of Radix Angelicae Sinensis 5---30 parts of Radixs Stephaniae Tetrandrae 4---
Caulis Piperis Kadsurae 4---20 parts in 25 parts of Radix Rehmanniae 5---30 portions of Ganodermas 4---
Pheretima 3---25 parts of 18 portions of Radix Notoginseng 3---18 parts of Caulis Sinomeniis 4---
The Chinese medicine of this treatment rheumatoid arthritis is made by following method:
(1) by above-mentioned weight ratio, Radix Gentianae Macrophyllae, Radix Angelicae Sinensis, Radix Stephaniae Tetrandrae, Caulis Piperis Kadsurae, the Radix Rehmanniae, Caulis Sinomenii are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Pheretima, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, make Chinese medicine granules, powder, capsule, watered pill, Tabules.
CN2009100832223A 2009-04-29 2009-04-29 Traditional Chinese medicine for treating chronic infectious arthritis Expired - Fee Related CN101874851B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009100832223A CN101874851B (en) 2009-04-29 2009-04-29 Traditional Chinese medicine for treating chronic infectious arthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009100832223A CN101874851B (en) 2009-04-29 2009-04-29 Traditional Chinese medicine for treating chronic infectious arthritis

Publications (2)

Publication Number Publication Date
CN101874851A CN101874851A (en) 2010-11-03
CN101874851B true CN101874851B (en) 2011-09-28

Family

ID=43017596

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009100832223A Expired - Fee Related CN101874851B (en) 2009-04-29 2009-04-29 Traditional Chinese medicine for treating chronic infectious arthritis

Country Status (1)

Country Link
CN (1) CN101874851B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102670833B (en) * 2012-06-04 2013-10-02 黄芸 Ramulus mori and radix rehmanniae traditional Chinese medicine oral liquid for relieving rheumatoid arthritis and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1686529A (en) * 2005-05-20 2005-10-26 李素梅 Ready prepared Chinese medicine for treating diabetes
CN1947777A (en) * 2006-06-18 2007-04-18 芮育健 Method for treating diabets by Fuling, wolfberry fruit and radix scrophulariae with producing saliva and slaking thirst function

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1686529A (en) * 2005-05-20 2005-10-26 李素梅 Ready prepared Chinese medicine for treating diabetes
CN1947777A (en) * 2006-06-18 2007-04-18 芮育健 Method for treating diabets by Fuling, wolfberry fruit and radix scrophulariae with producing saliva and slaking thirst function

Also Published As

Publication number Publication date
CN101874851A (en) 2010-11-03

Similar Documents

Publication Publication Date Title
CN101843787B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843699A (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101530461B (en) Traditional Chinese medicine for treating nasopharyngeal cancer
CN101843789B (en) Chinese medicament for treating gout
CN101884731B (en) Traditional Chinese medicine for treating silicosis
CN101843829B (en) Chinese medicament for treating pulmonary heart diseases
CN101843738A (en) Chinese medicament for treating diabetic feet
CN101843827B (en) Chinese medicament for treating gout
CN101843724B (en) Chinese medicament for treating gout
CN101850015B (en) Chinese medicament for treating arteriosclerosis
CN101843717B (en) Chinese medicament for treating coronary disease
CN101874851A (en) A kind of traditional Chinese medicine for treating rheumatoid arthritis
CN101843705B (en) Chinese medicament for treating lupus erythematosus
CN101843830B (en) Chinese medicament for treating pulmonary heart diseases
CN101843753B (en) Chinese medicament for treating angina
CN101843877B (en) Chinese medicament for treating liver cirrhosis
CN101537061B (en) Chinese medicine for treating liver cancer
CN101843731B (en) Chinese medicament for treating femoral head necrosis
CN101530479B (en) Traditional Chinese medicine for treating diabetes mellitus and muscle atrophy
CN101843741A (en) Chinese medicament for treating femoral head necrosis
CN101843754A (en) Chinese medicament for treating gout
CN101879259B (en) Traditional Chinese medicine for treating pulmonary heart diseases
CN101843879B (en) Chinese medicament for treating liver cirrhosis
CN101879244A (en) Traditional Chinese medicine for treating cerebral tumors
CN101850083B (en) Chinese medicament for treating asthma

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: SUZHOU DANFANG TEXTILE RESEARCH + DEVELOPMENT CO.,

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20150104

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 215228 SUZHOU, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20150104

Address after: 215228 Jiangsu City, Wujiang Province, Shengze Town, No. two West Ring Road, No. Shengze Textile Science and Technology Park, building 10, 1188

Patentee after: Suzhou Danfang Textile Research & Development Co., Ltd.

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110928

Termination date: 20190429